fbpx

Utrecht/London March 20 2019 – Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute (BCI) has boosted its radionuclide imaging capabilities with a MILabs VECTor PET/SPECT/CT omni-tomography system. Unlike other multi-modality PET/SPECT/CT systems, the VECTor technology enables the acquisition of PET and SPECT images simultaneously, co-registered in space and time. The system can acquire high-resolution images of virtually all diagnostic and radiotherapy radionuclides, fused with anatomical details provided by fast, ultra-low dose X-ray CT.

Dr. Jane Sosabowski, BCI’s Cancer Imaging group leader, states: “At the BCI, our researchers are conducting pioneering research in a variety of areas, including targeting tumor cells and the tumor microenvironment to identify new therapies for cancer, all of which would benefit from using the in vivo translational imaging techniques offered by the MILabs VECTor PET/SPECT/CT omni-tomography system. We strive to keep our molecular imaging facility up-to-date with state-of-the-art imaging equipment, including the latest technology for diagnostic and radiotherapy imaging, to ensure that we continue to push the bounds of cancer research”

Dr. Frederik Beekman, founder and CEO comments: “We are very pleased that a growing number of renowned molecular imaging research institutes is appreciating the advanced capabilities of our new generation VECTor-6 in vivo small animal imaging systems. Features such as omni-tomography of PET and SPECT, multi-isotope PET and PET-SPECT, positron range free PET, imaging of virtually all radiotherapy isotopes including alpha and beta emitters at sub-mm resolutions, low dose ultra-high resolution in vivo CT with multi-gating and fluoroscopy are expanding the application reach of molecular imaging beyond traditional diagnostic procedures.”

About Barts Cancer Institute:

The BCI at Queen Mary University of London is one of the leading cancer institutes in the UK and, as part of the Cancer Research UK (CRUK) Barts Centre, is recognized as a CRUK Centre of Excellence and a key partner in the CRUK City of London Centre. By investing in and undertaking world-class research, the institute’s overriding objective is to ensure that research conducted at the BCI is relevant to and will impact on cancer patients. BCI’s research staff and students focus their efforts on how to reduce the burden of disease through prevention; increase the chances of survival through early detection and diagnosis; and improve patient survival through the discovery and development of more effective and innovative therapies. A wide range of research is currently underway and includes:

  • Understanding the genetics and evolution of cancer
  • The development of novel molecular approaches for diagnosis
  • Understanding the basic biology of tumor cells and the tumor microenvironment to identify new targets for treatment
  • Pre-clinical and clinical trials exploring new therapeutic strategies

About MILabs

 MILabs has a history of providing a continuum of innovations to expand the applications of its multimodality imaging solutions used for the development of new diagnostic solutions and therapies. With its latest adaptive preclinical platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate PET, SPECT, Optical and CT imaging in a single integrated and user-friendly system.

Awarded the Commercial Innovation of the Year 2018 at the Molecular Imaging Congress, this platform is globally recognized for being able to deliver the highest quality molecular, functional and anatomical images.

For more information, visit:  www.milabs.com or contact MILabs at [email protected]

Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. …

Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value …

Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs …

Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V …

Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” …

Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and …

Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of …

Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …

Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …

Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …

Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …

Read More →

The University of Southampton enters the field of Correlative In-Vivo Imaging by Acquiring MILabs 3D/4D Optical/CT

May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …

Read More →
Scroll to Top